China Medical System Holdings Limited (HKG:0867)
11.95
-0.21 (-1.73%)
Aug 11, 2026, 2:55 PM HKT
HKG:0867 Market Cap
HKG:0867 has a market cap or net worth of 29.36 billion as of August 10, 2026. Its market cap has decreased by -8.66% in one year.
Market Cap
29.36B
Enterprise Value
23.85B
Revenue
9.14B
Ranking
n/a
PE Ratio
17.76
Stock Price
11.95
ChartMarket Cap Chart
Since September 28, 2010, HKG:0867's market cap has increased from 6.34B to 29.36B, an increase of 363.19%. That is a compound annual growth rate of 10.14%.
| Date | Market Cap | % Change |
|---|---|---|
| Aug 11, 2026 | 29.36B | -5.83% |
| Dec 31, 2025 | 31.17B | 70.86% |
| Dec 31, 2024 | 18.24B | -46.24% |
| Dec 29, 2023 | 33.94B | 12.70% |
| Dec 30, 2022 | 30.11B | -5.89% |
| Dec 31, 2021 | 32.00B | 49.54% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| Simcere Pharmaceutical Group | 31.97B |
| China Resources Pharmaceutical Group | 30.41B |
| Sunshine Lake Pharma | 20.42B |
| Grand Pharmaceutical Group | 18.33B |
| The United Laboratories International Holdings | 18.21B |
| Fujian Haixi Pharmaceuticals | 15.48B |
| Consun Pharmaceutical Group | 11.75B |
| Ab&B Bio-Tech CO., LTD. JS | 11.54B |